Viewing Study NCT04414969


Ignite Creation Date: 2025-12-24 @ 11:02 PM
Ignite Modification Date: 2025-12-24 @ 11:02 PM
Study NCT ID: NCT04414969
Status: UNKNOWN
Last Update Posted: 2020-07-07
First Post: 2020-05-31
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Anti-PD-1 Antibody Combined With Peg-Asparaginase and Chidamide for the Early Stage of NK/T Cell Lymphoma
Sponsor: Hunan Cancer Hospital
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module